Sökresultat

Filtyp

Din sökning på "*" gav 569972 sökträffar

MDC CV - IMT Adjusted 1991-2001

Name 1 MDC CV - IMT Adjusted 1991-2001 2023-09-26 Contents: Common carotid intima-media thickness (IMT) and carotid plaque data obtained from B-mode ultrasonography examination of the right carotid artery using an Acuson 128 CT system (Mountain View, CA, USA) with a 7-MHz transducer. IMT-data (used for examinations at baseline, BCAPS and HOMA). Another ultrasonography machine (which?) was used for

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2023-11/MDC%20CV%20-%20IMT%20Adjusted%201991-2001.pdf - 2026-09-26

MDC CV - Lab Results Baseline 1992-1994

Name 1 MDC CV - Lab results Baseline 1992-1994 2023-09-26 Contents: Laboratory analyses of blood samples, drawn after the baseline screening date. The blood sampling is considered baseline although it occurred about 9 months (mean 291 days, median 262 days, SD 135 days) after the initial baseline screening. # lines: 6 103 # variables: 17 Selection: Cardiovascular (CV) cohort of MDC. Every other in

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2023-11/MDC%20CV%20-%20Lab%20results%20Baseline%201992-1994.pdf - 2026-09-26

MDC Neck Shoulder Questionnaire

Name 1 MDC Neck Shoulder Questionnaire 2023-09-28 Contents: Data on occupational status, lifestyle factors, mechanical exposures and psychosocial factors, with particular focus on neck shoulder pain. # lines: 12 614 # variables: 339 Selection: Among 30 446 participants in the Malmö Diet and Cancer Study, 14 555 individuals who have filled in baseline questionnaire version 2 and been screened betwe

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2023-11/MDC%20Neck%20Shoulder%20Questionnaire.pdf - 2026-09-26

MDC Cellcounter

Name 1 MDC Cellcounter 2023-11-30 Contents: Cell counter (Sysmex K-1000) values. Cell counting was performed with a Sysmex K-1000, with related computer part DA 1000, Toa Medical Electronics, Japan, purchased in 1991. Data were generated from four main qualifiers (type of sample), all individuals have results from whole blood (QUAL=0). A marker (minus sign, "-") in front of all abnormal values (ou

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2024-01/MDC%20Cellcounter.pdf - 2026-09-26

Mos halvtidskontroll - variabellista 2019-02-20

MOS Variabellista inkl frekvenser - Halvtidskontroll (2018-06-13) Sida 1 av 50 Nr Name Format Variable label File Checked #B #BB Deltagare 1 lopnrMOS Numeric Löpnummer vid MOS baslinjeundersökning (Numerisk) MOS_Deltagare_halvtid.savAD 1326 1321 2 lopnrMOS_str8 String Löpnummer vid MOS baslinjeundersökning (Sträng, utan mellanstreck)MOS_Deltagare_halvtid.savAD 1326 1321 3 lopnrMOS_str9 String Löpn

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2024-03/mos_halvtidskontroll_-_variabellista_2019-02-20.pdf - 2026-09-26

Variabellista - mkc 2019-04-03

Variabler i MKC Sida 1 av 48 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 A B C D E F G Name Type Label N_obs File Comment Select (x) MKC bas (1991-1996) Frågeformulär lopnrMKC Numeric Baseline seque

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2024-03/variabellista_-_mkc_2019-04-03.pdf - 2026-09-26

ATC Codes Requested From The Prescribed Drug Register 2024 (MDC)

Bilaga2 Lista över sökta ATC-koder från Läkemedelsregistret – MKC Gäller data t o m 2024-12-31 Grupp Beskrivning A Matsmältningsorgan och ämnesomsättning B01A Antikoagulantia C Hjärta och kretslopp G Urin- och könsorgan samt könshormoner H Hormoner, exkl könshormoner och insuliner J Infektionssjukdomar L Tumörer och rubbningar i immunsystemet M Rörelseapparaten N02CC N04 N06D Selektiva serotonin (

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/ATC%20codes%20requested%20from%20the%20Prescribed%20Drug%20register%202024%20(MDC).pdf - 2026-09-26

MDC CV Rescr 2007-2012 (all Variables)

1 MDC CV rescr 2007-2012: Questionnaire 2013-01-18 Contents: Factors which are likely to have an effect on the emergence of cancer and cardiovascular diseases, such as occupation, physical activity, psychosocial environment, tobacco and alcohol consumption, health, diseases in the family, etc. Other variables are questions about PSA test (only men), hormonal replacement therapy and mammographic sc

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20CV%20rescr%202007-2012%20(all%20variables).pdf - 2026-09-26

MDC Cardiovascular Endpoints

Name 1 MDC Cardiovascular endpoints 2026-05-13 Contents: Cardiovascular events (coronary events, stroke, coronary artery bypass graft surgery (CABG), percu- taneous coronary artery intervention (PCI), heart failure, atrial fibrillation/flutter and aortic stenosis events), including diagnosis code and date of diagnosis. Separate variables were created for Major Adverse Coronary Events (MACE) based

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20Cardiovascular%20endpoints.pdf - 2026-09-26

MDC Dementia Endpoints

Name 1 MDC Dementia endpoints 2026-05-12 Contents: First prevalent and first incident events of three dementia disease groups: Alzheimer´s disease, vascular dementia and dementia UNS (unspecified), including diagnosis code, hospital and date of diagnosis. An individual can have both prevalent and incident events for a disease group. # lines: 30 446 # variables: 46 Version: The individuals have bee

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20Dementia%20endpoints.pdf - 2026-09-26

MDC Diabetes Endpoints

Name 1 MDC Diabetes endpoints 2026-05-13 Contents: Diabetes events, including date and type of diagnosis in first event, debut year, cardiovascular and kidney diseases (if available). # lines: 30 446 # variables: 38 Version: Data are updated annually. The individuals have been followed until their date of death, date of emigration, or until last follow-up date. Sources: Data have been derived from

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20Diabetes%20endpoints.pdf - 2026-09-26

MDC Event-based Cancer Endpoints

Name 1 MDC Event-based cancer endpoints 2026-05-12 Contents: Type of tumour and diagnosis date of individuals in the MDC cohort (n=30 446). Each tumour event is given on one data line. # variables: 29 Version: Data are updated annually. The individuals have been followed to until last follow-up date. Sources: Data have been derived from the Swedish Cancer Registry, SCR, at the National Board of He

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20Event-based%20cancer%20endpoints.pdf - 2026-09-26

MDC Multigeneration Register - List Of Variables And Codes

List of variables Name Index Dahlin Anders Tb: Index[x]=Data are available from index individuals Relative Dahlin Anders Tb: Relative[x]=Data are available from relatives Type Label N_obs 2023* File Select (x) Anders Dahlin: Instructions: 1) Put "x" for all desired variables in the Select-column 2) If a printed list with the selected variables is desired: - mark all columns and rows (Ctrl-A) - sor

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20Multigeneration%20register%20-%20List%20of%20variables%20and%20codes.xlsx - 2026-09-26

MDC Physical Activity MET LTPA

Name 1 MDC Physical activity MET LTPA 2025-04-11 Contents: Physical activity during leisure (including to and from work) according to question 37 (version 1), question 75 (version 2) and question 32 (version 3) in the questionnaire. Number of hours per week per activity, number of MET (Metabolic Equivalent Task) hours per week per activity, and two aggregated variables with total hours and total M

https://www.malmo-kohorter.lu.se/sites/malmo-kohorter.lu.se/files/2026-05/MDC%20Physical%20activity%20MET%20LTPA.pdf - 2026-09-26

Invitation 16th Annual MCC Retreat 2021 Final

Dear all, WELCOME to the 16th Annual MCC Retreat! Due to the corona pandemic, we will follow the Public Health Agency of Sweden’s regulations and general guidelines to reduce the spread of COVID-19. Since we do not know what the regulations are in September 2021, we will work to carry out the meeting as planned. If we must postpone the meeting, we will let you know not later than at the end of Jul

https://www.mcc.lu.se/sites/mcc.lu.se/files/2021-03/Invitation%2016th%20Annual%20MCC%20Retreat%202021%20final.pdf - 2026-09-26

Programme MCC Retreat 2022

Malmö Cancer Center Retreat 1-2 September 2022 Thursday September 1 8.00 Departure by bus from CRC, SUS Malmö, Jan Waldenströms gata 35 9.00 Arrival and coffee 9.30 Welcome address 9.40 – 10.40 MCC Special Guest Lecture Chairperson: Maria Alvarado Kristensson Thomas Helleday, Karolinska Institute, Stockholm and Sheffield University, UK “Targeting metabolism in the DNA damage response: from discove

https://www.mcc.lu.se/sites/mcc.lu.se/files/2022-09/Programme%20MCC%20retreat%202022.pdf - 2026-09-26

MCC 2024 Program Final

Malmö Cancer Center Retreat 5-6 September 2024 Thursday September 5 08.10 Departure by bus from CRC, SUS Malmö, Jan Waldenströms gata 35 09.10 Arrival and coffee at Ystad Saltsjöbad, Ystad 09.25 Welcome address 09.30 – 10.10 MCC Special Guest Lecture Chairperson: Daniel Förnvik Kamila Czene, Dept of Medical Epidemiology and Biostatistics, Karolinska Institutet “Improving Mammography Screening for

https://www.mcc.lu.se/sites/mcc.lu.se/files/2024-08/MCC%202024%20program%20final.pdf - 2026-09-26

MCC Retreat Program Final.

Malmö Cancer Center Retreat 5-6 September 2024 Thursday September 5 08.10 Departure by bus from CRC, SUS Malmö, Jan Waldenströms gata 35 09.10 Arrival and coffee at Ystad Saltsjöbad, Ystad 09.25 Welcome address 09.30 – 10.10 MCC Special Guest Lecture Chairperson: Daniel Förnvik Bruno Barufaldi , Institute for Translational Medicine and Therapeutics, University of Pennsylvania, USA “Virtual Clinica

https://www.mcc.lu.se/sites/mcc.lu.se/files/2024-09/MCC%20retreat%20program%20final..docx - 2026-09-26